{"id":"5a5e0c92-9d50-4bf1-b1ab-ae0d917797ea","modelId":"45105ba4-1c1f-4121-9ad4-bb912db1dcfc","versionId":null,"locationId":"70c916c7-d904-4fad-a62d-2359f4911580","operatorId":"e5127536-0ff2-4f0e-8488-64994cb2ffc7","ownerId":null,"slug":"intuitive-da-vinci-global-multi-site","status":"operational","firstSeen":"2000-07-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["surgical_assistance"],"shiftStructure":null,"hoursPerDay":8,"siteType":"hospital","operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":"city_centroid","deploymentScale":"large_100_plus","siteEnvironment":"indoor","operatorType":null,"sourceQualityTier":2,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://x.com/ReviewingNews/article/2058176073716707425","label":"Da Vinci 5 Surgical Robot: NVIDIA's 10,000x Compute Leap","title":"Da Vinci 5 Surgical Robot: NVIDIA's 10,000x Compute Leap","mediaType":"article","sourceName":"Reviewing News","publishedAt":"2000-07-01"}],"notes":"da Vinci surgical systems installed base of 11,395 systems globally as of Q1 2026. 431 systems installed in Q1 2026 alone. Most deployed surgical robot platform in the world. 4,500+ active patents.","keyFacts":[{"label":"Installed base","value":"11,395 systems"},{"label":"Q1 2026 installations","value":"431"}],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"healthcare","scaleTier":"mass_100_999","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-07-08T16:00:19.547Z","updatedAt":"2026-08-21T17:12:39.682Z","model":{"id":"45105ba4-1c1f-4121-9ad4-bb912db1dcfc","companyId":"e5127536-0ff2-4f0e-8488-64994cb2ffc7","modelName":"da Vinci (and Ion)","slug":"intuitive-da-vinci","description":"Intuitive Surgical (NASDAQ: ISRG; founded 1995, Sunnyvale, California) is the dominant incumbent and verified gold standard of surgical robotics. Its da Vinci platform spans the multi-port X and Xi systems, the SP single-port system, and the fifth-generation da Vinci 5, which the FDA cleared via 510(k) on March 14, 2024 with a headline Force Feedback sensing feature, alongside the Ion endoluminal robotic bronchoscopy system cleared in February 2019. As of its SEC Form 10-Q for the quarter ended March 31, 2026, the verified installed base was 11,395 da Vinci systems, up 12 percent year over year and including 1,464 da Vinci 5 units, plus 1,041 Ion systems, up 22 percent, with worldwide procedures growing about 17 percent. Surgical robotics sits in the registry as a deliberate axis-extension: physical AI operating in the medical regulatory regime, where FDA clearance is the verified gating event for maturity, and Intuitive clears it across multiple platforms and generations, placing it at production maturity. On AI substance, da Vinci is a master-slave teleoperated system with shipped analytics-grade AI such as Case Insights and machine-vision interface features, and Force Feedback is a shipped sensing feature rather than autonomy; autonomous suturing and tissue manipulation via vision-language models are research demonstrations on da Vinci hardware, not shipped features, and the 4,000-mile telesurgery demonstration is investigational. The widely cited 43-percent-less-force figure is preclinical and marketing-sourced rather than an outcomes-verified clinical result.","formFactor":"surgical","industryVertical":"healthcare","environment":"indoor","maturityStage":"production","lifecycleState":"active","supersededByModelId":null,"specs":{"dof":7,"notes":[{"label":"Verified (production anchor)","value":"Intuitive Surgical (NASDAQ: ISRG; founded 1995, Sunnyvale CA) is the dominant incumbent and the verified gold standard. VERIFIED installed base (SEC 10-Q, 3/31/2026): 11,395 da Vinci systems (+12% YoY), of which 1,464 are da Vinci 5; plus 1,041 Ion systems (+22% YoY). Q1 2026 procedures +17% worldwide; 431 da Vinci placed (232 of them da Vinci 5). da Vinci 5 FDA-cleared Mar 14 2024; Ion FDA-cleared Feb 2019."},{"label":"Axis-extension framing","value":"Surgical robotics is physical AI operating in the MEDICAL regulatory regime. FDA clearance is the verified gating event for maturity. Intuitive clears it across multiple platforms + generations -> production."},{"label":"AI-substance: teleop baseline + shipped analytics AI; autonomy demo-only","value":"da Vinci is master-slave teleoperated. SHIPPED AI: Case Insights (AI analysis of system/kinematics/video for surgeon performance) and machine-vision interface features; Force Feedback is a shipped sensing feature (not autonomy). Autonomous suturing/tissue-lifting via VLMs (Johns Hopkins/Stanford) are RESEARCH demonstrations on da Vinci hardware, NOT shipped. 4,000-mile telesurgery is investigational/in-development."},{"label":"Claimed but NOT verified","value":"'43% less force' is a preclinical/marketing figure, not an outcomes-verified clinical result. The 1,464 da Vinci 5 subfigure is company-reported (corroborated, model-level breakout)."}],"products":"da Vinci multi-port (X / Xi), da Vinci SP single-port, da Vinci 5 (5th-gen, FDA 510(k) Mar 14 2024, Force Feedback), and Ion endoluminal robotic bronchoscopy (FDA Feb 2019).","height_cm":175.3,"weight_kg":544,"formFactor":"surgical (teleoperated master-slave multi-port + single-port surgical robot; + endoluminal robotic bronchoscopy)","fda_clearance":"da Vinci 5 FDA 510(k) cleared March 14, 2024; Ion FDA cleared February 2019","clearance_body":"FDA"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/0001035267/000103526726000032/isrg-20260331.htm","title":"Intuitive Form 10-Q (Q1 2026): 11,395 da Vinci installed (1,464 da Vinci 5); 1,041 Ion","sourceName":"SEC EDGAR"},{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000029/q126ex-991earningsrelease.htm","title":"Intuitive Q1 2026 earnings (procedures +17%; 431 da Vinci placed; revenue $2.77B)","sourceName":"SEC EDGAR"},{"url":"https://www.globenewswire.com/news-release/2024/03/14/2846718/7637/en/Intuitive-Announces-FDA-Clearance-of-Fifth-Generation-Robotic-System-da-Vinci-5.html","title":"Intuitive: FDA clearance of da Vinci 5 (510(k), Mar 14 2024; Force Feedback)","sourceName":"Intuitive (GlobeNewswire)"},{"url":"https://www.therobotreport.com/intuitive-demos-4000-mile-telesurgery-with-da-vinci-5-surgical-robot/","title":"Intuitive demos 4,000-mile telesurgery (investigational, in development)","sourceName":"The Robot Report"},{"url":"https://www.fiercebiotech.com/medtech/intuitive-launches-latest-da-vinci-robot-force-feedback-controls","title":"da Vinci 5 Force Feedback (up to 43% less force, preclinical/marketing figure)","sourceName":"FierceBiotech"},{"url":"https://robotsguide.com/robots/davinci","title":"Da Vinci","sourceName":"Robots Guide"}],"aliases":["da Vinci","da Vinci 5","da Vinci Xi","da Vinci SP","Intuitive Ion"],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"Installed base","value":"11,395 da Vinci systems as of Q1 2026 (SEC 10-Q, 3/31/2026)"},{"label":"Production target","value":"431 da Vinci placed in Q1 2026 (232 of them da Vinci 5)"},{"label":"Autonomy level","value":"Master-slave teleoperated; shipped analytics AI (Case Insights, machine-vision); Force Feedback is sensing, not autonomy"},{"label":"Form factor","value":"Surgical teleoperated multi-port + single-port; plus endoluminal robotic bronchoscopy"},{"label":"FDA clearance","value":"da Vinci 5 FDA 510(k) cleared March 14, 2024; Ion FDA cleared February 2019"},{"label":"System price","value":"da Vinci Xi ~$1.5M; da Vinci 5 $1.8–2.5M (Forbes 2019; ACS Bulletin 2026; MedTech Dive analyst est.)"},{"label":"Per-procedure instrument cost","value":"$700–$3,200 per procedure in disposable instruments/accessories; ~$1,900 avg replacement parts per operation; instruments ~$2,300 for a 10-use device (PMC5644490; Forbes 2019; Meditek)"},{"label":"Annual service contract","value":"$100K–$175K per system per year (PMC5644490; r2surgical)"},{"label":"Revenue (FY2025)","value":"$10.06B total: Instruments & Accessories $6.02B (60%), Systems $2.47B (24%), Services $1.57B (16%) (10-K, bullfincher/SEC)"},{"label":"Gross margin","value":"Non-GAAP gross margin 69.1% in 2024; guided 65–66.5% for 2025 (Q1 2025 earnings release, SEC); GAAP gross profit $6.64B on $10.06B revenue in 2025"},{"label":"Component: arms","value":"Patient-side cart with 3–4 robotic arms; each arm uses multiple maxon DC motors (RE 25, RE 13 with GP 13 planetary gearheads, RE 35) — 30+ maxon motors per system; ironless rotor, rare-earth magnets for zero cogging (maxon group blog)"},{"label":"Component: vision/camera","value":"3D HD endoscope system; da Vinci 5 has 4x pixel resolution vs Xi, 785nm Firefly fluorescence imaging, tip heater anti-fog; endoscope list price ~$25,000 (Intuitive 2023 price list); camera control units, image synchronizers, high-intensity illuminators"},{"label":"Component: surgeon console","value":"Surgeon master controls with haptic feedback (da Vinci 5 adds Force Feedback); dual master manipulators with maxon motors; 3D stereoscopic viewer; ~150 design innovations in da Vinci 5; 10,000x computing power vs Xi"},{"label":"Component: instruments","value":"EndoWrist disposable instruments (forceps, scissors, needle drivers, scalpels, electrocautery) with wristed joints; 10-use limit per instrument; cannulas $630–683, arm drapes $378–1092, stapler reloads $2,898 (Intuitive 2023 price list)"},{"label":"Key supplier: maxon motors","value":"maxon group (Switzerland) supplies 30+ precision DC motors per system — RE 25, RE 13, RE 35 models with planetary gearheads and magnetic encoders; 10,000+ maxon motors in daily deployment (maxon blog, Intuitive mfg eng mgr quote)"},{"label":"Manufacturing","value":"Vertically integrated at Sunnyvale, CA campus (1050 Kifer Rd); in-house design, assembly, and testing; expanding manufacturing footprint and supply chain network (Intuitive careers, job postings for Sunnyvale supply chain roles)"},{"label":"Procedure volume","value":"3.1M+ da Vinci procedures in 2025 (+18% YoY); 300+ avg procedures per system per year; 20M+ cumulative procedures; 1,721 systems placed in 2025 (Intuitive 2025 annual report)"},{"label":"Razor-razorblade model","value":"60% of revenue from recurring instruments/accessories ($6.02B); systems only 24% ($2.47B); high-margin disposables drive economics — ~$1,900/procedure × 300 procedures/yr = ~$570K annual recurring revenue per installed system"}],"createdAt":"2026-06-03T20:12:00.111Z","updatedAt":"2026-07-22T17:19:25.655Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":"teleoperated","autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"e5127536-0ff2-4f0e-8488-64994cb2ffc7","name":"Intuitive Surgical","slug":"intuitive-surgical","description":"Dominant surgical-robotics maker (NASDAQ: ISRG; founded 1995, Sunnyvale CA) of the [da Vinci](/models/intuitive-da-vinci) teleoperated surgical robots and the Ion robotic bronchoscopy system; 11,000+ da Vinci installed worldwide.","status":"public (NASDAQ: ISRG)","founded":1995,"hq":"Sunnyvale, California, USA","hqLat":37.3688301,"hqLng":-122.036349,"hqGeocodedAt":"2026-08-05T14:34:41.542Z","hqAddress":null,"hqPrecision":null,"website":"https://intuitivesurgical.com","fundingTotal":null,"type":"both","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/0001035267/000103526726000032/isrg-20260331.htm","title":"Intuitive Form 10-Q (Q1 2026): 11,395 da Vinci installed (1,464 da Vinci 5); 1,041 Ion","sourceName":"SEC EDGAR"},{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000029/q126ex-991earningsrelease.htm","title":"Intuitive Q1 2026 earnings (procedures +17%; 431 da Vinci placed; revenue $2.77B)","sourceName":"SEC EDGAR"},{"url":"https://www.globenewswire.com/news-release/2024/03/14/2846718/7637/en/Intuitive-Announces-FDA-Clearance-of-Fifth-Generation-Robotic-System-da-Vinci-5.html","title":"Intuitive: FDA clearance of da Vinci 5 (510(k), Mar 14 2024; Force Feedback)","sourceName":"Intuitive (GlobeNewswire)"},{"url":"https://www.therobotreport.com/intuitive-demos-4000-mile-telesurgery-with-da-vinci-5-surgical-robot/","title":"Intuitive demos 4,000-mile telesurgery (investigational, in development)","sourceName":"The Robot Report"}],"keyFacts":[{"label":"Installed base","value":"11,395 da Vinci (1,464 da Vinci 5) + 1,041 Ion (SEC 10-Q, Q1 2026)."},{"label":"Gating events","value":"da Vinci 5 FDA-cleared Mar 14 2024; Ion FDA-cleared Feb 2019."},{"label":"Stock listing","value":"NASDAQ: ISRG"},{"label":"Market position","value":"Dominant surgical-robotics maker"},{"label":"da Vinci product type","value":"Teleoperated surgical robot"},{"label":"Ion product type","value":"Robotic bronchoscopy system"},{"label":"Hero image candidate","value":"https://upload.wikimedia.org/wikipedia/commons/7/77/New_Da_Vinci_Xi.jpg (source: Wikimedia Commons, license: CC BY-SA 4.0)"},{"label":"Manufacturing","value":"Vertically integrated — manufactures da Vinci Xi, SP, and 5 systems in-house at Sunnyvale campus (surgeon console, patient side cart, instruments). 99%+ uptime."}],"aliases":["Intuitive","ISRG","da Vinci","Intuitive Surgical Inc","da Vinci robot","da Vinci surgical system"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"ISRG","stockExchange":"NASDAQ","secCik":"0001035267","revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-03T20:11:59.344Z","updatedAt":"2026-08-22T03:20:46.710Z"}},"version":null,"location":{"id":"70c916c7-d904-4fad-a62d-2359f4911580","name":"Global (multiple sites)","slug":"global-multi-site","kind":"site","parentLocationId":null,"region":"International","lat":null,"lng":null,"reviewStatus":"reviewed","aliases":[],"collisionRisk":"high","reviewNote":"Ungeocodable: non-geographic or multi-region location","createdAt":"2026-07-08T15:41:15.330Z","updatedAt":"2026-08-04T14:18:19.338Z"},"operator":{"id":"e5127536-0ff2-4f0e-8488-64994cb2ffc7","name":"Intuitive Surgical","slug":"intuitive-surgical","description":"Dominant surgical-robotics maker (NASDAQ: ISRG; founded 1995, Sunnyvale CA) of the [da Vinci](/models/intuitive-da-vinci) teleoperated surgical robots and the Ion robotic bronchoscopy system; 11,000+ da Vinci installed worldwide.","status":"public (NASDAQ: ISRG)","founded":1995,"hq":"Sunnyvale, California, USA","hqLat":37.3688301,"hqLng":-122.036349,"hqGeocodedAt":"2026-08-05T14:34:41.542Z","hqAddress":null,"hqPrecision":null,"website":"https://intuitivesurgical.com","fundingTotal":null,"type":"both","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/0001035267/000103526726000032/isrg-20260331.htm","title":"Intuitive Form 10-Q (Q1 2026): 11,395 da Vinci installed (1,464 da Vinci 5); 1,041 Ion","sourceName":"SEC EDGAR"},{"url":"https://www.sec.gov/Archives/edgar/data/1035267/000103526726000029/q126ex-991earningsrelease.htm","title":"Intuitive Q1 2026 earnings (procedures +17%; 431 da Vinci placed; revenue $2.77B)","sourceName":"SEC EDGAR"},{"url":"https://www.globenewswire.com/news-release/2024/03/14/2846718/7637/en/Intuitive-Announces-FDA-Clearance-of-Fifth-Generation-Robotic-System-da-Vinci-5.html","title":"Intuitive: FDA clearance of da Vinci 5 (510(k), Mar 14 2024; Force Feedback)","sourceName":"Intuitive (GlobeNewswire)"},{"url":"https://www.therobotreport.com/intuitive-demos-4000-mile-telesurgery-with-da-vinci-5-surgical-robot/","title":"Intuitive demos 4,000-mile telesurgery (investigational, in development)","sourceName":"The Robot Report"}],"keyFacts":[{"label":"Installed base","value":"11,395 da Vinci (1,464 da Vinci 5) + 1,041 Ion (SEC 10-Q, Q1 2026)."},{"label":"Gating events","value":"da Vinci 5 FDA-cleared Mar 14 2024; Ion FDA-cleared Feb 2019."},{"label":"Stock listing","value":"NASDAQ: ISRG"},{"label":"Market position","value":"Dominant surgical-robotics maker"},{"label":"da Vinci product type","value":"Teleoperated surgical robot"},{"label":"Ion product type","value":"Robotic bronchoscopy system"},{"label":"Hero image candidate","value":"https://upload.wikimedia.org/wikipedia/commons/7/77/New_Da_Vinci_Xi.jpg (source: Wikimedia Commons, license: CC BY-SA 4.0)"},{"label":"Manufacturing","value":"Vertically integrated — manufactures da Vinci Xi, SP, and 5 systems in-house at Sunnyvale campus (surgeon console, patient side cart, instruments). 99%+ uptime."}],"aliases":["Intuitive","ISRG","da Vinci","Intuitive Surgical Inc","da Vinci robot","da Vinci surgical system"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"ISRG","stockExchange":"NASDAQ","secCik":"0001035267","revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-03T20:11:59.344Z","updatedAt":"2026-08-22T03:20:46.710Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/intuitive-da-vinci-global-multi-site","url":"https://registry.deploy.report/deployments/intuitive-da-vinci-global-multi-site","name":"da Vinci (and Ion) at Global (multiple sites)","identifier":"5a5e0c92-9d50-4bf1-b1ab-ae0d917797ea","startDate":"2000-07-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/global-multi-site","name":"Global (multiple sites)"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/intuitive-surgical","name":"Intuitive Surgical"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/intuitive-da-vinci","name":"da Vinci (and Ion)"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"production","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}